as on
| Source : NSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
0.83%
Downside
0.68%
Upside
52 Week's Low
52 Week's High
11.79%
Downside
32.08%
Upside
Market Stats | |
Previous Close | ₹2,656.50 |
Open | ₹2,650.20 |
Volume | 51.05K |
Upper Circuit | ₹3,187.80 |
Lower Circuit | ₹2,125.20 |
Day's Low | ₹2,616.5 |
Day's High | ₹2,656.5 |
52 Week Low | ₹2,327.3 |
52 Week High | ₹3,485 |
Returns % | |
1 Month Return | -3.05 % |
3 Month Return | + 3.23 % |
1 Year Return | -14.94 % |
3 Year Return | + 104.8 % |
5 Year Return | + 147.33 % |
Check Ajanta Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹33,189.15 Cr
Return on Equity (ROE)
26.05
PE Ratio (TTM)
35.75
Return on capital employed (ROCE)
32.78
Industry PE ratio
43.37
Beta (LTM)
0.71
P/B Ratio
9.05
Dividend Yield
1.07
PEG Ratio
5.52
Quarterly Earnings Growth YOY
3.89
EPS (TTM)
73.43
Sector
Pharmaceuticals
Book Value
302.38
Technical Analysis
Bearish
View Technical Analysis
Track how Ajanta Pharma Ltd P/E has moved over time to understand its valuation trends.
Ajanta Pharma Ltd in the last 5 years
Lowest (17.12x)
June 6, 2018
Today (35.75x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (50.52x)
September 10, 2024
Today’s Price to Earnings Ratio: 35.75x
Get updated buy, sell, and hold recommendations by analysts on Ajanta Pharma Ltd.
based on 12 analysts
66.67%
Buy
16.67%
Hold
16.67%
Sell
66.67% of analysts recommend a 'BUY' rating for Ajanta Pharma Ltd. Average target price of ₹3008.33
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Ajanta Pharma Ltd.
Ajanta Pharma Ltd price forecast by 12 analysts
Upside of13.24%
High
₹3293
Target
₹3008.33
Low
₹2307
Ajanta Pharma Ltd target price ₹3008.33, a slight upside of 13.24% compared to current price of ₹2638.5. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Ajanta Pharma Ltd revenue growth forecast
Expected growth rate Q1, FY2027:26.25%
Forecast
Actual
Including amortisation and stock based compensations
Ajanta Pharma Ltd EPS growth forecast
EPS estimate Q1, FY2027:32.90%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Ajanta Pharma Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Ajanta Pharma Ltd.
Ajanta Pharma Ltd’s net profit jumped 3.89% since last year same period to ₹255.34Cr in the Q1 2025-2026. On a quarterly growth basis, Ajanta Pharma Ltd has generated 13.35% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28.00 per share on 28 Oct 2024 - translating a dividend yield of 2.03%.
Read More about DividendsCheck stock indices that include Ajanta Pharma Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ajanta Pharma Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 66.26% | 0.00 | |
Foreign Institutions | 8.86% | ||
Mutual Funds | 14.72% | ||
Retail Investors | 7.38% | ||
Others | 2.78% | 17.77 |
Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 33,189.15 | 29.47% | 0.52 | 920 | 4,648 | |
BUY | 12,139.11 | -7.93% | 0.52 | 413 | 2,013 | |
BUY | 60,996.21 | 3.95% | 0.60 | 3,483 | 31,723 | |
HOLD | 99,194.55 | 29.9% | 0.61 | 4,614 | 23,241 | |
BUY | 69,349.38 | 18.45% | 0.00 | 1,414 | 6,445 |
Latest news and events in one place to help you make informed investing decisions in Ajanta Pharma Ltd.
Ajanta Pharma Reports Strong Sales Growth in June 2025 - 29 Jul, 2025
Ajanta Pharma Reports Strong Q1 Earnings Growth - 28 Jul, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 225.26 Cr → 255.34 Cr (in ₹), with an average increase of 11.8% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 1.17K Cr → 1.32K Cr (in ₹), with an average increase of 5.8% per quarter
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 8.86% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 34.1%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 37.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 66.26% of holdings in Jun 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 7.39% to 7.38% in Jun 2025 quarter
Price Dip
In the last 7 days, AJANTPHARM stock has moved down by -1.3%
MF Holding Down
Mutual Funds have decreased holdings from 15.13% to 14.72% in Jun 2025 quarter
Organisation | Ajanta Pharma Ltd |
Industry | Pharmaceuticals |
CEO | Mannalal B Agrawal |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Ajanta Pharma Ltd.
Ajanta Pharma Ltd share price today stands at ₹2638.5, Open: ₹2650.2, Previous Close: ₹2656.5, High: ₹2656.5, Low: ₹2616.5, 52 Week High: ₹3485, 52 Week Low: ₹2327.3 as on .
To buy Ajanta Pharma Ltd shares, you need to follow these steps:
Today's traded volume of Ajanta Pharma Ltd is 51.05K. Which means that 51.05K shares of Ajanta Pharma Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Ajanta Pharma Ltd is ₹33,189.15 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Ajanta Pharma Ltd’s 52 week high is ₹3485 and 52 week low is ₹2327.3. The current share price of Ajanta Pharma Ltd is ₹2638.5, which is -24.29% down from its 52 week high and 13.37% up from its 52 week low.